Project Details
Description
A Phase 3 Prospective, Randomized, Double Masked, 12-Week, Parallel, Group Study Evaluating the Efficacy and Safety of Latanoprost and Timolol in Pediatric Subjects with Glaucoma
| Status | Finished |
|---|---|
| Effective start/end date | 2/9/09 → 12/31/10 |
Funding
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.